Early Directed Physical Therapy in the Management of Mechanically Ventilated Patients in a Medical Intensive Care Unit

Sponsor
University of Chicago (Other)
Overall Status
Completed
CT.gov ID
NCT00322010
Collaborator
University of Iowa (Other)
104
1
2
28
3.7

Study Details

Study Description

Brief Summary

To study all ICU patients with an independent baseline functional status, who experience a critical illness requiring intubation and mechanical ventilation, evaluating the role of protocol-directed, early physical and occupational therapy on the incidence of critical illness associated functional debilitation. Our goal is to hasten the recovery of independent physical functioning as well as to reduce ICU delirium in the group of patients who begin this intervention from the earliest hours of ventilator dependence.

Condition or Disease Intervention/Treatment Phase
  • Procedure: early PT OT
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
104 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized Trial of Early Physical and Occupational Therapy in Mechanically Ventilated, Critically Ill Patients
Study Start Date :
Jun 1, 2005
Actual Primary Completion Date :
Oct 1, 2007
Actual Study Completion Date :
Oct 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: Early PT OT

Early PT/OT Therapy assessments to begin on the first day that consent is obtained. Therapy is delivered by a team consisting of a physical and occupational therapist and coordinated with daily sedative interruption.

Procedure: early PT OT
Passive range of motion exercises for all limbs in patients who remain unresponsive despite sedative interruption (ten repetitions in all cardinal directions). Sessions began with active assisted and active range of motion exercises in the supine position. If tolerated, treatment is advanced to bed mobility activities, including transferring to upright sitting. Sitting balance activities are followed by participation in activities of daily living (ADLs) and exercises that encourage increased independence with functional tasks. The session progresses to transfer training, and finally pre-gait exercises and ambulation. Progression of activities is dependent on patient tolerance and stability. Therapy intervention continues on a daily basis throughout the patient's hospital stay until he/she returns to prior level of function or is discharged.

No Intervention: Standard Care

PT/OT delivered as ordered by the primary ICU team

Outcome Measures

Primary Outcome Measures

  1. Number of patients returning to independent functional status: defined as ability to perform 6 activities of daily living (ADL's)(bathing, dressing, eating, grooming, transfer from bed to chair, toileting) and independent ambulation [Hospital Discharge]

Secondary Outcome Measures

  1. Number of hospital days with delirium [Hospital discharge]

  2. Number of days alive and breathing without assistance (ventilator-free days) [during 28-day study period]

  3. length of stay [ICU and Hospital discharge]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria

  1. Patients intubated and mechanical ventilated for < 72 hours

  2. Age > 18 years

  3. Baseline independent functional status as assessed by a Barthel Index score > 70 collected from a proxy reflecting baseline health 2 weeks prior to critical illness

Exclusion Criteria

  1. Rapidly evolving neurological/neuromuscular disease

  2. Cardiac arrest

  3. Irreversible conditions with six month mortality estimated at > 50%

  4. Elevated intracranial pressure

  5. Multiple absent limbs (precluding complete musculoskeletal examination)

  6. Enrollment in another trial

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Chicago Chicago Illinois United States 60637

Sponsors and Collaborators

  • University of Chicago
  • University of Iowa

Investigators

  • Principal Investigator: John P Kress, MD, University of Chicago

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Chicago
ClinicalTrials.gov Identifier:
NCT00322010
Other Study ID Numbers:
  • 13766B
First Posted:
May 4, 2006
Last Update Posted:
Mar 18, 2014
Last Verified:
Mar 1, 2014

Study Results

No Results Posted as of Mar 18, 2014